Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
19
datasets available to search
ShareScore release 0.9.0
Dataset results
19 results for “pharmacoeconomic”
Data from: Pharmacoeconomic study of anti-influenza virus drugs in Japan based on a network meta-analysis
<p><strong>Objectives:</strong> An analysis was conducted in Japan to determine the most cost-effective neuraminidase inhibitor for the treatment of influenza virus infections from the healthcare payer's standpoint.</p> <p><strong>Methods:</strong> This study reanalyzed the findings of a previous study that had some limitations (no probabilistic sensitivity analysis, quality of life scores measured by the EQ-5D-3L instead of the EQ-5D-5L, and the use of a decision tree model with only three health conditions) by using data from a network meta-analysis study. A decision tree model with eight health conditions was constructed, and costs were identified as medical costs and drug prices (the 2020 version of the Japanese medical fee index). The effectiveness outcomes were measured using EQ-5D-5L questionnaires for adult patients who had previously experienced influenza virus infections. The time horizon was 14 days. Both deterministic and probabilistic sensitivity analyses were performed to examine the robustness of the results.</p> <p><strong>Results:</strong> The base-case cost-effectiveness analysis revealed that oseltamivir outperformed laninamivir, zanamivir, and peramivir, making it the most cost-effective neuraminidase inhibitor. The deterministic and probabilistic sensitivity analyses showed robust results that validated oseltamivir as the most cost-effective among the four neuraminidase inhibitors.</p> <p><strong>Conclusions:</strong> This study thus reconfirmed oseltamivir's position as the most cost-effective neuraminidase inhibitor for the treatment of influenza virus infections in Japan from the standpoint of healthcare payment. These findings can help decision-makers and healthcare providers in Japan, including pharmacists, create and manage formularies.</p>
Heparin Induced Thrombocytopenia: Pharmacoeconomics
ClinicalTrials.gov study NCT00456001. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients
ClinicalTrials.gov study NCT02041468. IPD Sharing: UNDECIDED. Countries: 1. Publications: 5.
Pharmacoeconomic Evaluation of the Cost/effectiveness Ratio of Physical Exercise on Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT06026293. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A pharmacoeconomic study of post-exposure prophylaxis strategies for influenza virus infections in Japan
Open the record for dataset details and reuse information.
Data from: Pharmacoeconomic study of anti-influenza virus drugs in Japan based on a network meta-analysis
Open the record for dataset details and reuse information.
Pharmacoeconomics and Related Patient Outcomes of Multi-dose Intravenous Acetaminophen (OFIRMEV)
ClinicalTrials.gov study NCT02369211. IPD Sharing: NO. Countries: 1. Publications: 0.
Pharmacoeconomic Consequences Of Analgesia in the Intensive Care Unit (ICU)
ClinicalTrials.gov study NCT00436345. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Clinical and Pharmacoeconomic Impact of Rapid Diagnostic Test (Multiplex PCR FilmArray) on Antimicrobial Decision Making Compared to Conventional Decision Making Among Critically Ill Patients
ClinicalTrials.gov study NCT05759494. IPD Sharing: UNDECIDED. Countries: 0. Publications: 4.
PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00173524. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate Real-world Pharmacoeconomics of Panitumumab in Metastatic Colorectal Cancer Patients
ClinicalTrials.gov study NCT02139215. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies
ClinicalTrials.gov study NCT01178346. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients
ClinicalTrials.gov study NCT02228421. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate Real-world Pharmacoeconomics and Resistance Mechanisms of Panitumumab in Metastatic Colorectal Cancer Patients
ClinicalTrials.gov study NCT02135757. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacoeconomic Study Assessing the Cost of Chronic Hepatitis C Treatment With Peginterferon Alfa-2b (PegIntron) and Ribavirin (Rebetol) in the Czech Republic (Study P04588)(COMPLETED)
ClinicalTrials.gov study NCT00723632. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04296214. IPD Sharing: NO. Countries: 1. Publications: 0.
A Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in Egypt
ClinicalTrials.gov study NCT05195086. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacoeconomic Analysis of First Line Meropenem Versus Standard Antibiotic Treatment in Seriously Infected Secondary Nosocomial Sepsis Syndrome Patients.
ClinicalTrials.gov study NCT00318552. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Retrospective Pharmacoeconomic Study of Lung Cancer
ClinicalTrials.gov study NCT01140958. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.